Morgan Stanley
ZURA icon

Morgan Stanley’s Zura Bio ZURA Stock Holding History

Morgan Stanley’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.19M Sell
872,950
-636,461
-42% -$3.84M ﹤0.01% 4104
2025
Q4 		$7.91M Buy
1,509,411
+1,299,985
+621% +$5.14M ﹤0.01% 3813
2025
Q3 		$907K Sell
209,426
-39,774
-16% -$71.5K ﹤0.01% 5221
2025
Q2 		$262K Buy
249,200
+165,291
+197% +$198K ﹤0.01% 5744
2025
Q1 		$108K Sell
83,909
-30,199
-26% -$47.6K ﹤0.01% 5973
2024
Q4 		$285K Sell
114,108
-16,842
-13% -$60K ﹤0.01% 5652
2024
Q3 		$532K Buy
130,950
+95,505
+269% +$357K ﹤0.01% 5372
2024
Q2 		$124K Buy
35,445
+13,285
+60% +$54.2K ﹤0.01% 5882
2024
Q1 		$57K Sell
22,160
-94,808
-81% -$336K ﹤0.01% 6164
2023
Q4 		$546K Buy
116,968
+99,885
+585% +$499K ﹤0.01% 5584
2023
Q3 		$113K Buy
17,083
+11,657
+215% +$77.9K ﹤0.01% 5835
2023
Q2 		$44.5K Buy
+5,426
New +$43.6K ﹤0.01% 6255

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Morgan Stanley's ZURA Position: Q1 2026 in Review

Morgan Stanley reduced its Zura Bio (ZURA) stake by 42% in Q1 2026, selling an estimated $3.84M and leaving 872,950 shares worth $5.19M. The position accounts for ﹤0.01% of the portfolio, ranked #4104.

Morgan Stanley first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.91M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Morgan Stanley held 872,950 shares of Zura Bio worth $5.19M as of Q1 2026.
  • Morgan Stanley sold 636,461 Zura Bio shares in Q1 2026, an estimated $3.84M.
  • Zura Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4104 holding.
  • Morgan Stanley first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • Morgan Stanley's Zura Bio position peaked at $7.91M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.